Antibody response to COVID-19 vaccination in immunosuppressed patients with autoimmune disease
Latest Information Update: 18 Apr 2022
At a glance
- Drugs AZD 1222 (Primary) ; Tozinameran (Primary)
- Indications COVID 2019 infections
- Focus Therapeutic Use
- Acronyms RESCUE
- 04 Jun 2021 New trial record